First examples of tetracyclic triterpenoids with a D:B-friedobaccharane skeleton. A tentative biosynthetic route

Tetrahedron Letters

Volumn 45, Issue 39, 2004, Pages 7367-7370

  Núñez, Marvin J ^a   López, Manuel R ^a   Jiménez, Ignacio A ^a   Moujir, Laila M ^a   Ravelo, Angel G ^a   Bazzocchi, Isabel L ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Biosynthetic route; Celastraceae; D:B friedobaccharanes; Tetracyclic triterpenoids

Indexed keywords

BARUOL; BETA GLUCURONIDASE; CATION; PHENOBARBITAL; TRITERPENOID; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; MAYTENUS BLEPHARODES; MAYTENUS CHIAPENSIS; MEDICINAL PLANT; MOLECULAR MODEL; SPECTROSCOPY;

CELASTRACEAE; MAYTENUS;

EID: 4444316234     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2004.07.133     Document Type: Article

References (19)

1. A.G. González, I.L. Bazzocchi, L.M. Moujir, and I.A. Jiménez A. Rahman Studies in Natural Products Chemistry, Bioactive Natural Products (Part D) Vol. 23 2000 Elsevier Amsterdam 649 738
2. M.L. Kennedy, M.S. Cortés-Selva, J.M. Pérez-Victoria, I.A. Jiménez, A.G. González, O.M. Muñoz, F. Gamarro, S. Castanys, and A.G. Ravelo J. Med. Chem. 44 2001 4668 4676
3. P.M. Dewick Medicinal Natural Products. A Biosynthetic Approach 1998 John Wiley & Sons Chichester pp 195-200
4. N. Shoji, A. Umeyama, Z. Taira, T. Takemoto, K. Nomoto, K. Mizukawa, and Y. Ohizumi J. Chem. Soc., Chem. Commun. 1983 871 873
5. T. Akihisa, K. Yasukawa, Y. Kimura, S. Yamanouchi, and T. Tamura Phytochemistry 48 1998 301 305
6. Maytenus blepharodes Lundell was collected at Volcán Baru, Chiriqui, Panamá and Maytenus chiapiensis Lundell was collected at Parque Nacional El Imposible, Cerro El León, El Salvador. Voucher specimen are on file at the Department of Medicinal Chemistry and Pharmacognosy, University of Panamá and at the Jardin Botánico, La Laguna, El Salvador, respectively
7. S. Sang-Bum, K. Nam-Jae, and K. Dong-Hyun Planta Med. 66 2000 40 43
8. +, 8), 411 (5), 408 (5), 393 (3), 385 (2), 274 (100), 259 (81), 205 (20), 189 (38), 152 (16), 134 (71), 95 (63), 69 (90)
9. A.G. González, E.A. Ferro, and A.G. Ravelo Phytochemistry 26 1987 2785 2788
10. Macromodel 4.0, Schrödinger, Inc., Portland, Oregon, USA
11. K.U. Wendt, G.E. Schulz, E.J. Corey, and D.R. Liu Angew. Chem., Int. Ed. 39 2000 2812 2833 and references cited therein
12. R. Xu, G.C. Fazio, and S.P.T. Matsuda Phytochemistry 65 2004 261 291
13. +, 4), 422 (6), 407 (4), 288 (17), 273 (22), 189 (32), 152 (50), 134 (100), 95 (74), 69 (52)
14. R. Fröde, M. Bröckelmann, B. Steffan, and W. Steglich Tetrahedron 51 1995 2553 2569
15. The antimicrobial activity was evaluated against Gram-positive (Staphylococcus aureus, S. epidermidis, Bacillus subtilis, B. pumilus, B. cereus, B. megaterium, Enterococcus faecalis, Mycobacterium smegmatis), and Gram-negative (Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Salmonella sp.) bacteria, and a yeast (Candida albicans) by the macrodilution method as previously described by L. Moujir, A.M. Gutiérrez-Navarro, A.J. González, A.G. Ravelo, and J.G. Luis Biochem. Syst. Ecol. 18 1990 25 28
16. The cytotoxic activity was evaluated against HeLa (human carcinoma of the cervix) and Hep-2 (human carcinoma of the larynx) cell lines as previously described by S. Kasugai, N. Hasegawa, and H. Ogura Jpn. J. Pharmacol. 52 1990 95 100
17. Xanthine oxidase (from cow's milk) inhibitory activity was measured, using xanthine as subtrate, according to previous work (González, A. G.; Bazzocchi, I. L.; Moujir, L.; Ravelo, A. G.; Correa, M. D.; Gupta, M. P. J Ethnopharm. 1995, 46, 25-29)
18. β-Glucuronidase (from bovine liver) inhibitory activity was measured, using p-nitrophenyl β-d-glucuronide as substrate, as previously described by M. Kawasaki, T. Hayashi, M. Arisawa, N. Morita, and L.H. Berganza Phytochemistry 27 1988 3709 3711
19. β-Glucosidase (from bitter almonds emulsion) inhibitory activity was measured, using p-nitrophenyl Î-glucopyranoside, as substrate, as previously described by M.D. Antoun, Y.R. Ríos, N.T. Mendoza, and G. Proctor Puerto Rico Health Sci. J. 13 1994 13 15